Page last updated: 2024-11-04
sulfinpyrazone and Kahler Disease
sulfinpyrazone has been researched along with Kahler Disease in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Witwer, MW | 1 |
Schmid, FR | 1 |
Tesar, JT | 1 |
Other Studies
1 other study available for sulfinpyrazone and Kahler Disease
Article | Year |
---|---|
Acute myelomonocytic leukaemia and multiple myeloma after sulphinpyrazone and colchicine treatment of gout.
Topics: Aged; Colchicine; Gout; Humans; Leukemia, Myeloid, Acute; Male; Multiple Myeloma; Sulfinpyrazone | 1976 |